

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | lysine metabolic process (GO:0006553) | 5.38618285 |
| 2 | lysine catabolic process (GO:0006554) | 5.38618285 |
| 3 | proline biosynthetic process (GO:0006561) | 5.21454359 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.07853661 |
| 5 | L-phenylalanine metabolic process (GO:0006558) | 5.07853661 |
| 6 | DNA unwinding involved in DNA replication (GO:0006268) | 5.07096421 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 4.93548372 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.93548372 |
| 9 | glyoxylate metabolic process (GO:0046487) | 4.74811460 |
| 10 | Golgi transport vesicle coating (GO:0048200) | 4.72293080 |
| 11 | COPI coating of Golgi vesicle (GO:0048205) | 4.72293080 |
| 12 | alpha-linolenic acid metabolic process (GO:0036109) | 4.72155486 |
| 13 | glycine metabolic process (GO:0006544) | 4.70588167 |
| 14 | cysteine metabolic process (GO:0006534) | 4.62904501 |
| 15 | mitotic chromosome condensation (GO:0007076) | 4.55264569 |
| 16 | 2-oxoglutarate metabolic process (GO:0006103) | 4.48635053 |
| 17 | kynurenine metabolic process (GO:0070189) | 4.36460029 |
| 18 | serine family amino acid catabolic process (GO:0009071) | 4.33386525 |
| 19 | sulfur amino acid catabolic process (GO:0000098) | 4.27378269 |
| 20 | aromatic amino acid family catabolic process (GO:0009074) | 4.25890862 |
| 21 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.22794412 |
| 22 | serine family amino acid biosynthetic process (GO:0009070) | 4.19312612 |
| 23 | serine family amino acid metabolic process (GO:0009069) | 4.13621257 |
| 24 | negative regulation of fibrinolysis (GO:0051918) | 4.10300865 |
| 25 | homocysteine metabolic process (GO:0050667) | 4.07098060 |
| 26 | nuclear pore complex assembly (GO:0051292) | 4.04436939 |
| 27 | aspartate family amino acid catabolic process (GO:0009068) | 4.02844725 |
| 28 | amino-acid betaine metabolic process (GO:0006577) | 4.00450040 |
| 29 | urea cycle (GO:0000050) | 3.99377274 |
| 30 | urea metabolic process (GO:0019627) | 3.99377274 |
| 31 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.95936189 |
| 32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.92788442 |
| 33 | bile acid biosynthetic process (GO:0006699) | 3.85604291 |
| 34 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.85362945 |
| 35 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.85011581 |
| 36 | regulation of cholesterol homeostasis (GO:2000188) | 3.85010212 |
| 37 | valine metabolic process (GO:0006573) | 3.82928941 |
| 38 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.82863284 |
| 39 | acetyl-CoA metabolic process (GO:0006084) | 3.81922906 |
| 40 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.80887836 |
| 41 | tricarboxylic acid metabolic process (GO:0072350) | 3.80625990 |
| 42 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.80356568 |
| 43 | 4-hydroxyproline metabolic process (GO:0019471) | 3.75957049 |
| 44 | oxaloacetate metabolic process (GO:0006107) | 3.70162102 |
| 45 | tryptophan catabolic process (GO:0006569) | 3.70133348 |
| 46 | indole-containing compound catabolic process (GO:0042436) | 3.70133348 |
| 47 | indolalkylamine catabolic process (GO:0046218) | 3.70133348 |
| 48 | ethanol oxidation (GO:0006069) | 3.67155673 |
| 49 | proline metabolic process (GO:0006560) | 3.66227138 |
| 50 | fatty acid beta-oxidation (GO:0006635) | 3.65996957 |
| 51 | L-serine metabolic process (GO:0006563) | 3.65445121 |
| 52 | nitrogen cycle metabolic process (GO:0071941) | 3.65263711 |
| 53 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.64824923 |
| 54 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.64633584 |
| 55 | cellular protein complex localization (GO:0034629) | 3.61523883 |
| 56 | alpha-amino acid catabolic process (GO:1901606) | 3.60898602 |
| 57 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.58297088 |
| 58 | protein carboxylation (GO:0018214) | 3.58297088 |
| 59 | regulation of triglyceride catabolic process (GO:0010896) | 3.57251300 |
| 60 | regulation of early endosome to late endosome transport (GO:2000641) | 3.57210310 |
| 61 | protein retention in ER lumen (GO:0006621) | 3.57102800 |
| 62 | regulation of protein activation cascade (GO:2000257) | 3.56540416 |
| 63 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.55895152 |
| 64 | cellular modified amino acid catabolic process (GO:0042219) | 3.54022532 |
| 65 | protein complex localization (GO:0031503) | 3.52173186 |
| 66 | complement activation, alternative pathway (GO:0006957) | 3.52140845 |
| 67 | tryptophan metabolic process (GO:0006568) | 3.51884986 |
| 68 | formation of translation preinitiation complex (GO:0001731) | 3.51747098 |
| 69 | negative regulation of cholesterol transport (GO:0032375) | 3.50422962 |
| 70 | negative regulation of sterol transport (GO:0032372) | 3.50422962 |
| 71 | regulation of fibrinolysis (GO:0051917) | 3.50178850 |
| 72 | low-density lipoprotein particle clearance (GO:0034383) | 3.48926361 |
| 73 | one-carbon metabolic process (GO:0006730) | 3.48075624 |
| 74 | high-density lipoprotein particle remodeling (GO:0034375) | 3.47173608 |
| 75 | plasma lipoprotein particle clearance (GO:0034381) | 3.46569954 |
| 76 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.46052008 |
| 77 | adherens junction assembly (GO:0034333) | 3.46033032 |
| 78 | tetrahydrofolate metabolic process (GO:0046653) | 3.45395206 |
| 79 | fatty acid oxidation (GO:0019395) | 3.45047813 |
| 80 | fatty acid transmembrane transport (GO:1902001) | 3.42472089 |
| 81 | cellular amino acid catabolic process (GO:0009063) | 3.40720466 |
| 82 | triglyceride homeostasis (GO:0070328) | 3.40273344 |
| 83 | acylglycerol homeostasis (GO:0055090) | 3.40273344 |
| 84 | focal adhesion assembly (GO:0048041) | 3.36177323 |
| 85 | cell-substrate adherens junction assembly (GO:0007045) | 3.36177323 |
| 86 | regulation of complement activation (GO:0030449) | 3.35567964 |
| 87 | short-chain fatty acid metabolic process (GO:0046459) | 3.35314519 |
| 88 | lipid oxidation (GO:0034440) | 3.34744014 |
| 89 | carnitine metabolic process (GO:0009437) | 3.34177929 |
| 90 | cellular ketone body metabolic process (GO:0046950) | 3.34141982 |
| 91 | DNA replication initiation (GO:0006270) | 3.33331615 |
| 92 | glucose 6-phosphate metabolic process (GO:0051156) | 3.32779645 |
| 93 | tricarboxylic acid cycle (GO:0006099) | 3.32704949 |
| 94 | apoptotic process involved in morphogenesis (GO:0060561) | 3.32594113 |
| 95 | glutamate metabolic process (GO:0006536) | 3.32162994 |
| 96 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.31843867 |
| 97 | carnitine shuttle (GO:0006853) | 3.31545756 |
| 98 | negative regulation of cell size (GO:0045792) | 3.31395764 |
| 99 | nuclear pore organization (GO:0006999) | 3.31266195 |
| 100 | protein localization to endosome (GO:0036010) | 3.30581736 |
| 101 | regulation of fatty acid oxidation (GO:0046320) | 3.30002324 |
| 102 | aromatic amino acid family metabolic process (GO:0009072) | 3.26230722 |
| 103 | bile acid metabolic process (GO:0008206) | 3.25302893 |
| 104 | tyrosine metabolic process (GO:0006570) | 3.24995784 |
| 105 | fatty acid catabolic process (GO:0009062) | 3.20689980 |
| 106 | positive regulation of fatty acid oxidation (GO:0046321) | 3.20074505 |
| 107 | heterochromatin organization (GO:0070828) | 3.19706400 |
| 108 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.19102275 |
| 109 | fatty acid homeostasis (GO:0055089) | 3.18241214 |
| 110 | regulation of translational fidelity (GO:0006450) | 3.18178044 |
| 111 | NADH metabolic process (GO:0006734) | 3.18080542 |
| 112 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.17389807 |
| 113 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.15055439 |
| 114 | regulation of RNA export from nucleus (GO:0046831) | 3.12130885 |
| 115 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.11821693 |
| 116 | DNA strand elongation (GO:0022616) | 3.09644366 |
| 117 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.08773746 |
| 118 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.08320362 |
| 119 | regulation of translational termination (GO:0006449) | 3.08202250 |
| 120 | positive regulation of nuclease activity (GO:0032075) | 3.08106179 |
| 121 | mitotic sister chromatid segregation (GO:0000070) | 3.07872254 |
| 122 | ketone body metabolic process (GO:1902224) | 3.07777775 |
| 123 | organic acid catabolic process (GO:0016054) | 3.06252385 |
| 124 | carboxylic acid catabolic process (GO:0046395) | 3.06252385 |
| 125 | monocarboxylic acid catabolic process (GO:0072329) | 3.06208129 |
| 126 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.06109903 |
| 127 | folic acid metabolic process (GO:0046655) | 3.04700409 |
| 128 | activation of Rac GTPase activity (GO:0032863) | 3.04664059 |
| 129 | positive regulation of lipid catabolic process (GO:0050996) | 3.03272172 |
| 130 | reverse cholesterol transport (GO:0043691) | 3.02418237 |
| 131 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.02281766 |
| 132 | RNA stabilization (GO:0043489) | 3.01275449 |
| 133 | mRNA stabilization (GO:0048255) | 3.01275449 |
| 134 | phospholipid homeostasis (GO:0055091) | 3.00195209 |
| 135 | pentose-phosphate shunt (GO:0006098) | 2.99502282 |
| 136 | coenzyme catabolic process (GO:0009109) | 2.99141334 |
| 137 | ribosomal small subunit biogenesis (GO:0042274) | 2.99085179 |
| 138 | dicarboxylic acid metabolic process (GO:0043648) | 2.98119223 |
| 139 | maternal placenta development (GO:0001893) | 2.97918057 |
| 140 | protein export from nucleus (GO:0006611) | 2.97182489 |
| 141 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.97074847 |
| 142 | branched-chain amino acid metabolic process (GO:0009081) | 2.96325773 |
| 143 | benzene-containing compound metabolic process (GO:0042537) | 2.95942498 |
| 144 | macromolecular complex remodeling (GO:0034367) | 2.95501846 |
| 145 | pore complex assembly (GO:0046931) | 2.94890556 |
| 146 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.93736835 |
| 147 | DNA duplex unwinding (GO:0032508) | 2.88878459 |
| 148 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.88441466 |
| 149 | mannose metabolic process (GO:0006013) | 2.87374604 |
| 150 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.86509233 |
| 151 | basement membrane organization (GO:0071711) | 2.85086629 |
| 152 | regulation of histone H3-K27 methylation (GO:0061085) | 2.83692818 |
| 153 | protein-DNA complex disassembly (GO:0032986) | 2.82689506 |
| 154 | nucleosome disassembly (GO:0006337) | 2.82689506 |
| 155 | protein maturation by protein folding (GO:0022417) | 2.82556313 |
| 156 | regulation of translational elongation (GO:0006448) | 2.81746684 |
| 157 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.81632907 |
| 158 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059) | 2.81155951 |
| 159 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.80710656 |
| 160 | regulation of nuclease activity (GO:0032069) | 2.77946271 |
| 161 | ER-nucleus signaling pathway (GO:0006984) | 2.76868915 |
| 162 | chromosome condensation (GO:0030261) | 2.74710549 |
| 163 | NADPH regeneration (GO:0006740) | 2.73887712 |
| 164 | histone arginine methylation (GO:0034969) | 2.73498353 |
| 165 | glucose catabolic process (GO:0006007) | 2.72251508 |
| 166 | sister chromatid segregation (GO:0000819) | 2.70965631 |
| 167 | cell-substrate junction assembly (GO:0007044) | 2.69888359 |
| 168 | protein localization to chromosome, centromeric region (GO:0071459) | 2.66635308 |
| 169 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 2.65246969 |
| 170 | mitotic nuclear envelope disassembly (GO:0007077) | 2.64812516 |
| 171 | UV protection (GO:0009650) | 2.64206922 |
| 172 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.63395868 |
| 173 | mitochondrial fusion (GO:0008053) | 2.63263510 |
| 174 | DNA geometric change (GO:0032392) | 2.62965532 |
| 175 | peptidyl-arginine N-methylation (GO:0035246) | 2.61058392 |
| 176 | peptidyl-arginine methylation (GO:0018216) | 2.61058392 |
| 177 | glycolytic process (GO:0006096) | 2.60022271 |
| 178 | regulation of chromatin binding (GO:0035561) | 2.59083579 |
| 179 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.57703079 |
| 180 | cellular response to unfolded protein (GO:0034620) | 2.57228563 |
| 181 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.55196963 |
| 182 | membrane disassembly (GO:0030397) | 2.53828304 |
| 183 | nuclear envelope disassembly (GO:0051081) | 2.53828304 |
| 184 | monosaccharide biosynthetic process (GO:0046364) | 2.52938833 |
| 185 | pinocytosis (GO:0006907) | 2.52895909 |
| 186 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.52403487 |
| 187 | snRNA metabolic process (GO:0016073) | 2.51072960 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.52370204 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.97454654 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.39381624 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.19173847 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.90376752 |
| 6 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.30583752 |
| 7 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.87870669 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.74277376 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.53616504 |
| 10 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.49682004 |
| 11 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.47378447 |
| 12 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.37975650 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.37828057 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.26122676 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.25344576 |
| 16 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.20265090 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.12869130 |
| 18 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.11658679 |
| 19 | MYC_22102868_ChIP-Seq_BL_Human | 2.01866773 |
| 20 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.01222216 |
| 21 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.88381776 |
| 22 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.86522462 |
| 23 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.85831393 |
| 24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.83108944 |
| 25 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.77450783 |
| 26 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.73027025 |
| 27 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.71941117 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.71227316 |
| 29 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.68646225 |
| 30 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.63986118 |
| 31 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.60886847 |
| 32 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.58488258 |
| 33 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.56805230 |
| 34 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.56144984 |
| 35 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.50916383 |
| 36 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.50014784 |
| 37 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.47727584 |
| 38 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.43606865 |
| 39 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.43340013 |
| 40 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.42518678 |
| 41 | KDM2B_26808549_Chip-Seq_K562_Human | 1.41642645 |
| 42 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.35569875 |
| 43 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.33759438 |
| 44 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.33674715 |
| 45 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.32414960 |
| 46 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.30212984 |
| 47 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.29383321 |
| 48 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.27999147 |
| 49 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.27595406 |
| 50 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.27542750 |
| 51 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.27192643 |
| 52 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.26943072 |
| 53 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.24665041 |
| 54 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.24200866 |
| 55 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.21426316 |
| 56 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.21324285 |
| 57 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.21313714 |
| 58 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.20784039 |
| 59 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.20276450 |
| 60 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.20029544 |
| 61 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.18987354 |
| 62 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.17849479 |
| 63 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.16878475 |
| 64 | MAF_26560356_Chip-Seq_TH1_Human | 1.16752204 |
| 65 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.15792863 |
| 66 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.14016368 |
| 67 | MAF_26560356_Chip-Seq_TH2_Human | 1.12722676 |
| 68 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.12305454 |
| 69 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.12269343 |
| 70 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.11990283 |
| 71 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.11124405 |
| 72 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09735199 |
| 73 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.09140957 |
| 74 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08876807 |
| 75 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.07743844 |
| 76 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.07661203 |
| 77 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.06803630 |
| 78 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06406430 |
| 79 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06059654 |
| 80 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.05570686 |
| 81 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.05482360 |
| 82 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.04649914 |
| 83 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.04169538 |
| 84 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.04165820 |
| 85 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.03003641 |
| 86 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02838309 |
| 87 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.02803641 |
| 88 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.02407853 |
| 89 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.02184959 |
| 90 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.01023036 |
| 91 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.00707833 |
| 92 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.00358559 |
| 93 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.00144687 |
| 94 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99670447 |
| 95 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.99576883 |
| 96 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.99219027 |
| 97 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.98638650 |
| 98 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.97506576 |
| 99 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.97252426 |
| 100 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.96842271 |
| 101 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.96530658 |
| 102 | UTX_26944678_Chip-Seq_JUKART_Human | 0.95855390 |
| 103 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.94270966 |
| 104 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.93475708 |
| 105 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.93353406 |
| 106 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.92260464 |
| 107 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.92108433 |
| 108 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.90071083 |
| 109 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.89412652 |
| 110 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.88812987 |
| 111 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88241875 |
| 112 | P68_20966046_ChIP-Seq_HELA_Human | 0.88178060 |
| 113 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.86613015 |
| 114 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.86596740 |
| 115 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.85952100 |
| 116 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.85718200 |
| 117 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85461889 |
| 118 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.85413377 |
| 119 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.84714762 |
| 120 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.84159876 |
| 121 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.83913519 |
| 122 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.83730502 |
| 123 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.83674706 |
| 124 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.82561722 |
| 125 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.81845960 |
| 126 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.81642414 |
| 127 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.81349400 |
| 128 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.80729647 |
| 129 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.80416978 |
| 130 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.80416978 |
| 131 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.80321441 |
| 132 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.79244867 |
| 133 | GATA1_22025678_ChIP-Seq_K562_Human | 0.79086634 |
| 134 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.79038656 |
| 135 | * GABP_19822575_ChIP-Seq_HepG2_Human | 0.79032823 |
| 136 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78632448 |
| 137 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.78603893 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.61369017 |
| 2 | MP0005360_urolithiasis | 5.10930169 |
| 3 | MP0005365_abnormal_bile_salt | 4.07964700 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 4.07578936 |
| 5 | MP0003806_abnormal_nucleotide_metabolis | 3.79790228 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.57493717 |
| 7 | MP0009840_abnormal_foam_cell | 2.96592657 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 2.94319133 |
| 9 | MP0003252_abnormal_bile_duct | 2.73492007 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.71289828 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.57752661 |
| 12 | MP0005083_abnormal_biliary_tract | 2.37282414 |
| 13 | MP0004858_abnormal_nervous_system | 2.36033988 |
| 14 | MP0005332_abnormal_amino_acid | 2.08659121 |
| 15 | MP0010094_abnormal_chromosome_stability | 2.03812551 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 2.02079179 |
| 17 | MP0000678_abnormal_parathyroid_gland | 1.94363024 |
| 18 | MP0005670_abnormal_white_adipose | 1.90006912 |
| 19 | MP0009278_abnormal_bone_marrow | 1.88460701 |
| 20 | MP0000609_abnormal_liver_physiology | 1.87408188 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.82981353 |
| 22 | MP0005666_abnormal_adipose_tissue | 1.81540584 |
| 23 | MP0008260_abnormal_autophagy | 1.77356592 |
| 24 | MP0003453_abnormal_keratinocyte_physiol | 1.74980866 |
| 25 | MP0004130_abnormal_muscle_cell | 1.73065017 |
| 26 | MP0001666_abnormal_nutrient_absorption | 1.67568523 |
| 27 | MP0005319_abnormal_enzyme/_coenzyme | 1.65467435 |
| 28 | MP0000350_abnormal_cell_proliferation | 1.63889356 |
| 29 | MP0004185_abnormal_adipocyte_glucose | 1.63507499 |
| 30 | MP0010352_gastrointestinal_tract_polyps | 1.61418864 |
| 31 | MP0003195_calcinosis | 1.59174171 |
| 32 | MP0000537_abnormal_urethra_morphology | 1.58924785 |
| 33 | MP0004084_abnormal_cardiac_muscle | 1.58641405 |
| 34 | MP0002118_abnormal_lipid_homeostasis | 1.58263592 |
| 35 | MP0005257_abnormal_intraocular_pressure | 1.46879997 |
| 36 | MP0008932_abnormal_embryonic_tissue | 1.46792858 |
| 37 | MP0008438_abnormal_cutaneous_collagen | 1.46530189 |
| 38 | MP0001348_abnormal_lacrimal_gland | 1.41690022 |
| 39 | MP0005501_abnormal_skin_physiology | 1.40992181 |
| 40 | MP0002269_muscular_atrophy | 1.39328940 |
| 41 | MP0005330_cardiomyopathy | 1.38144704 |
| 42 | MP0004808_abnormal_hematopoietic_stem | 1.37300269 |
| 43 | MP0002089_abnormal_postnatal_growth/wei | 1.35424610 |
| 44 | MP0003646_muscle_fatigue | 1.33261614 |
| 45 | MP0006036_abnormal_mitochondrial_physio | 1.30949151 |
| 46 | MP0003091_abnormal_cell_migration | 1.29808424 |
| 47 | MP0008007_abnormal_cellular_replicative | 1.27751941 |
| 48 | MP0002796_impaired_skin_barrier | 1.26559374 |
| 49 | MP0000598_abnormal_liver_morphology | 1.25531826 |
| 50 | MP0005409_darkened_coat_color | 1.23890203 |
| 51 | MP0002060_abnormal_skin_morphology | 1.23180683 |
| 52 | MP0005375_adipose_tissue_phenotype | 1.22806940 |
| 53 | MP0009643_abnormal_urine_homeostasis | 1.22524769 |
| 54 | MP0003221_abnormal_cardiomyocyte_apopto | 1.22417310 |
| 55 | MP0003329_amyloid_beta_deposits | 1.22349822 |
| 56 | MP0004019_abnormal_vitamin_homeostasis | 1.21422245 |
| 57 | MP0004087_abnormal_muscle_fiber | 1.21414941 |
| 58 | MP0005623_abnormal_meninges_morphology | 1.20882465 |
| 59 | MP0003566_abnormal_cell_adhesion | 1.20478756 |
| 60 | MP0002396_abnormal_hematopoietic_system | 1.19309797 |
| 61 | MP0005621_abnormal_cell_physiology | 1.19012099 |
| 62 | MP0008057_abnormal_DNA_replication | 1.15678636 |
| 63 | MP0002249_abnormal_larynx_morphology | 1.15608360 |
| 64 | MP0010630_abnormal_cardiac_muscle | 1.13671926 |
| 65 | MP0003172_abnormal_lysosome_physiology | 1.11088049 |
| 66 | MP0001730_embryonic_growth_arrest | 1.10743851 |
| 67 | MP0005076_abnormal_cell_differentiation | 1.10408142 |
| 68 | MP0010234_abnormal_vibrissa_follicle | 1.09507292 |
| 69 | MP0003186_abnormal_redox_activity | 1.08813004 |
| 70 | MP0003123_paternal_imprinting | 1.08744139 |
| 71 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.08538093 |
| 72 | MP0000750_abnormal_muscle_regeneration | 1.08046151 |
| 73 | MP0000313_abnormal_cell_death | 1.07605700 |
| 74 | MP0009333_abnormal_splenocyte_physiolog | 1.07151634 |
| 75 | MP0000858_altered_metastatic_potential | 1.05610167 |
| 76 | MP0000751_myopathy | 1.03028337 |
| 77 | MP0010030_abnormal_orbit_morphology | 1.02096362 |
| 78 | MP0004957_abnormal_blastocyst_morpholog | 1.01961412 |
| 79 | MP0000747_muscle_weakness | 1.01835738 |
| 80 | MP0009672_abnormal_birth_weight | 1.00555410 |
| 81 | MP0004233_abnormal_muscle_weight | 0.98512225 |
| 82 | MP0002971_abnormal_brown_adipose | 0.97990247 |
| 83 | MP0005384_cellular_phenotype | 0.97213734 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 0.96978039 |
| 85 | MP0004197_abnormal_fetal_growth/weight/ | 0.96498890 |
| 86 | MP0005023_abnormal_wound_healing | 0.96013038 |
| 87 | MP0002085_abnormal_embryonic_tissue | 0.95818064 |
| 88 | MP0003984_embryonic_growth_retardation | 0.94978577 |
| 89 | MP0002088_abnormal_embryonic_growth/wei | 0.94957809 |
| 90 | MP0010307_abnormal_tumor_latency | 0.92943849 |
| 91 | MP0008775_abnormal_heart_ventricle | 0.92031851 |
| 92 | MP0004036_abnormal_muscle_relaxation | 0.91600947 |
| 93 | MP0000490_abnormal_crypts_of | 0.90572788 |
| 94 | MP0003567_abnormal_fetal_cardiomyocyte | 0.90526548 |
| 95 | MP0003868_abnormal_feces_composition | 0.90180612 |
| 96 | MP0009053_abnormal_anal_canal | 0.89633553 |
| 97 | MP0002138_abnormal_hepatobiliary_system | 0.89548428 |
| 98 | MP0001672_abnormal_embryogenesis/_devel | 0.89467384 |
| 99 | MP0005380_embryogenesis_phenotype | 0.89467384 |
| 100 | MP0005266_abnormal_metabolism | 0.89322204 |
| 101 | MP0006035_abnormal_mitochondrial_morpho | 0.88212123 |
| 102 | MP0003111_abnormal_nucleus_morphology | 0.87639406 |
| 103 | MP0006138_congestive_heart_failure | 0.85974668 |
| 104 | MP0002877_abnormal_melanocyte_morpholog | 0.85247894 |
| 105 | MP0003693_abnormal_embryo_hatching | 0.85168495 |
| 106 | MP0005385_cardiovascular_system_phenoty | 0.84647523 |
| 107 | MP0001544_abnormal_cardiovascular_syste | 0.84647523 |
| 108 | MP0008961_abnormal_basal_metabolism | 0.84124311 |
| 109 | MP0002970_abnormal_white_adipose | 0.83353636 |
| 110 | MP0002084_abnormal_developmental_patter | 0.82643934 |
| 111 | MP0009931_abnormal_skin_appearance | 0.82573122 |
| 112 | MP0002086_abnormal_extraembryonic_tissu | 0.80654915 |
| 113 | MP0000003_abnormal_adipose_tissue | 0.80297949 |
| 114 | MP0005451_abnormal_body_composition | 0.80050853 |
| 115 | MP0004947_skin_inflammation | 0.79866046 |
| 116 | MP0003300_gastrointestinal_ulcer | 0.79402278 |
| 117 | MP0002078_abnormal_glucose_homeostasis | 0.78703570 |
| 118 | MP0001764_abnormal_homeostasis | 0.78602288 |
| 119 | MP0003115_abnormal_respiratory_system | 0.77251130 |
| 120 | MP0005220_abnormal_exocrine_pancreas | 0.76138284 |
| 121 | MP0005334_abnormal_fat_pad | 0.74286763 |
| 122 | MP0002080_prenatal_lethality | 0.74197040 |
| 123 | MP0001915_intracranial_hemorrhage | 0.73980095 |
| 124 | MP0001697_abnormal_embryo_size | 0.72554305 |
| 125 | MP0001661_extended_life_span | 0.71829130 |
| 126 | MP0009115_abnormal_fat_cell | 0.71493077 |
| 127 | MP0000749_muscle_degeneration | 0.71419352 |
| 128 | MP0003077_abnormal_cell_cycle | 0.70387678 |
| 129 | MP0001216_abnormal_epidermal_layer | 0.70369141 |
| 130 | MP0001849_ear_inflammation | 0.68573179 |
| 131 | MP0003959_abnormal_lean_body | 0.67970320 |
| 132 | MP0004215_abnormal_myocardial_fiber | 0.67879203 |
| 133 | MP0000733_abnormal_muscle_development | 0.67702077 |
| 134 | MP0001756_abnormal_urination | 0.67168475 |
| 135 | MP0003634_abnormal_glial_cell | 0.66888572 |
| 136 | MP0002019_abnormal_tumor_incidence | 0.66693702 |
| 137 | MP0000358_abnormal_cell_content/ | 0.65885502 |
| 138 | MP0004782_abnormal_surfactant_physiolog | 0.65836525 |
| 139 | MP0000467_abnormal_esophagus_morphology | 0.65762466 |
| 140 | MP0005397_hematopoietic_system_phenotyp | 0.65320387 |
| 141 | MP0001545_abnormal_hematopoietic_system | 0.65320387 |
| 142 | MP0009763_increased_sensitivity_to | 0.65036948 |
| 143 | MP0000759_abnormal_skeletal_muscle | 0.64681318 |
| 144 | MP0000566_synostosis | 0.64594890 |
| 145 | MP0003385_abnormal_body_wall | 0.64049865 |
| 146 | MP0010368_abnormal_lymphatic_system | 0.63151578 |
| 147 | MP0000266_abnormal_heart_morphology | 0.61866686 |
| 148 | MP0005636_abnormal_mineral_homeostasis | 0.60158279 |
| 149 | MP0004272_abnormal_basement_membrane | 0.59535588 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.05570448 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 4.61109559 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.54132124 |
| 4 | Xanthomatosis (HP:0000991) | 4.54033607 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.35409423 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 4.08511138 |
| 7 | Hyperacusis (HP:0010780) | 4.07301775 |
| 8 | Hyperammonemia (HP:0001987) | 4.05143942 |
| 9 | Hyperglycinuria (HP:0003108) | 4.02313938 |
| 10 | Hypoglycemic coma (HP:0001325) | 3.96948322 |
| 11 | Ketosis (HP:0001946) | 3.86663565 |
| 12 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.81668918 |
| 13 | Abnormality of glycine metabolism (HP:0010895) | 3.81668918 |
| 14 | Hyperglycinemia (HP:0002154) | 3.72924593 |
| 15 | Hypolipoproteinemia (HP:0010981) | 3.50101780 |
| 16 | Hyperlipoproteinemia (HP:0010980) | 3.41120519 |
| 17 | Hypoalphalipoproteinemia (HP:0003233) | 3.37680283 |
| 18 | Myoglobinuria (HP:0002913) | 3.28902694 |
| 19 | Ketoacidosis (HP:0001993) | 3.27066415 |
| 20 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.24719395 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.23550998 |
| 22 | Ulnar bowing (HP:0003031) | 3.20411700 |
| 23 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.15646732 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.14682317 |
| 25 | Complement deficiency (HP:0004431) | 3.12823778 |
| 26 | Spastic diplegia (HP:0001264) | 3.11878946 |
| 27 | Premature rupture of membranes (HP:0001788) | 3.08510500 |
| 28 | Insomnia (HP:0100785) | 3.05155908 |
| 29 | Epidermoid cyst (HP:0200040) | 3.01262854 |
| 30 | Rhabdomyolysis (HP:0003201) | 2.93811959 |
| 31 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.81110939 |
| 32 | Prolonged partial thromboplastin time (HP:0003645) | 2.78974823 |
| 33 | Multiple enchondromatosis (HP:0005701) | 2.78742700 |
| 34 | Vertebral compression fractures (HP:0002953) | 2.73943099 |
| 35 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.72989649 |
| 36 | Abnormality of the common coagulation pathway (HP:0010990) | 2.72713802 |
| 37 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.72325158 |
| 38 | Dicarboxylic aciduria (HP:0003215) | 2.72325158 |
| 39 | Progressive muscle weakness (HP:0003323) | 2.70771568 |
| 40 | Dysmetric saccades (HP:0000641) | 2.68227427 |
| 41 | Long palpebral fissure (HP:0000637) | 2.65806937 |
| 42 | Abnormal cartilage morphology (HP:0002763) | 2.65598800 |
| 43 | Gout (HP:0001997) | 2.64389828 |
| 44 | Increased connective tissue (HP:0009025) | 2.63673888 |
| 45 | Distal lower limb amyotrophy (HP:0008944) | 2.62275569 |
| 46 | Skin nodule (HP:0200036) | 2.62043034 |
| 47 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.60724139 |
| 48 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.60185924 |
| 49 | Disproportionate tall stature (HP:0001519) | 2.55898581 |
| 50 | Abnormality of methionine metabolism (HP:0010901) | 2.54497521 |
| 51 | Hepatocellular carcinoma (HP:0001402) | 2.53142047 |
| 52 | Abnormality of the intrinsic pathway (HP:0010989) | 2.52757153 |
| 53 | Exercise-induced muscle cramps (HP:0003710) | 2.52644667 |
| 54 | Abnormality of serum amino acid levels (HP:0003112) | 2.51255306 |
| 55 | Cholelithiasis (HP:0001081) | 2.44771803 |
| 56 | Abnormality of complement system (HP:0005339) | 2.41700347 |
| 57 | Abnormality of nucleobase metabolism (HP:0010932) | 2.38517602 |
| 58 | Hypercholesterolemia (HP:0003124) | 2.38089049 |
| 59 | Reticulocytosis (HP:0001923) | 2.37360787 |
| 60 | Late onset (HP:0003584) | 2.37341156 |
| 61 | Abnormality of the Achilles tendon (HP:0005109) | 2.37044907 |
| 62 | Lymphangioma (HP:0100764) | 2.34471821 |
| 63 | Myocardial infarction (HP:0001658) | 2.32792308 |
| 64 | Biconcave vertebral bodies (HP:0004586) | 2.30522252 |
| 65 | Hyperbilirubinemia (HP:0002904) | 2.29501675 |
| 66 | Cholecystitis (HP:0001082) | 2.28903374 |
| 67 | Abnormal gallbladder physiology (HP:0012438) | 2.28903374 |
| 68 | Neonatal onset (HP:0003623) | 2.27917570 |
| 69 | Abnormal gallbladder morphology (HP:0012437) | 2.27700249 |
| 70 | Abnormality of purine metabolism (HP:0004352) | 2.27414333 |
| 71 | Protrusio acetabuli (HP:0003179) | 2.26511278 |
| 72 | Right ventricular cardiomyopathy (HP:0011663) | 2.25009115 |
| 73 | Trismus (HP:0000211) | 2.23693940 |
| 74 | Back pain (HP:0003418) | 2.22509479 |
| 75 | Abnormality of the thoracic spine (HP:0100711) | 2.21686775 |
| 76 | Broad face (HP:0000283) | 2.20178419 |
| 77 | Fat malabsorption (HP:0002630) | 2.18910547 |
| 78 | Sparse lateral eyebrow (HP:0005338) | 2.16647171 |
| 79 | Myopathic facies (HP:0002058) | 2.14465299 |
| 80 | Metabolic acidosis (HP:0001942) | 2.12818361 |
| 81 | Ragged-red muscle fibers (HP:0003200) | 2.11635271 |
| 82 | Ankyloglossia (HP:0010296) | 2.09195827 |
| 83 | Esophageal varix (HP:0002040) | 2.08563617 |
| 84 | Lethargy (HP:0001254) | 2.05723102 |
| 85 | Thin bony cortex (HP:0002753) | 2.04418922 |
| 86 | Shallow orbits (HP:0000586) | 2.03701184 |
| 87 | Overriding aorta (HP:0002623) | 2.02227938 |
| 88 | Delayed CNS myelination (HP:0002188) | 2.01876091 |
| 89 | Premature skin wrinkling (HP:0100678) | 2.00815367 |
| 90 | Fragile skin (HP:0001030) | 2.00665292 |
| 91 | Renal duplication (HP:0000075) | 2.00464960 |
| 92 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.99818172 |
| 93 | Joint hemorrhage (HP:0005261) | 1.99552363 |
| 94 | Nausea (HP:0002018) | 1.99310223 |
| 95 | Hyperglycemia (HP:0003074) | 1.99051149 |
| 96 | Distal lower limb muscle weakness (HP:0009053) | 1.98385157 |
| 97 | Turricephaly (HP:0000262) | 1.98102045 |
| 98 | Pointed chin (HP:0000307) | 1.98044485 |
| 99 | Broad distal phalanx of finger (HP:0009836) | 1.97886126 |
| 100 | Elbow flexion contracture (HP:0002987) | 1.97387583 |
| 101 | Hydroxyprolinuria (HP:0003080) | 1.97357797 |
| 102 | Abnormality of proline metabolism (HP:0010907) | 1.97357797 |
| 103 | Pseudobulbar signs (HP:0002200) | 1.96925731 |
| 104 | Elfin facies (HP:0004428) | 1.96397273 |
| 105 | Polycythemia (HP:0001901) | 1.95975488 |
| 106 | Abnormality of reticulocytes (HP:0004312) | 1.95864939 |
| 107 | Truncus arteriosus (HP:0001660) | 1.95242086 |
| 108 | Spinal rigidity (HP:0003306) | 1.94711337 |
| 109 | Achilles tendon contracture (HP:0001771) | 1.94006134 |
| 110 | Abnormality of the calcaneus (HP:0008364) | 1.93417339 |
| 111 | Hyperuricemia (HP:0002149) | 1.93330383 |
| 112 | Increased purine levels (HP:0004368) | 1.93330383 |
| 113 | Flat acetabular roof (HP:0003180) | 1.91485490 |
| 114 | Patellar dislocation (HP:0002999) | 1.91057919 |
| 115 | Cerebral aneurysm (HP:0004944) | 1.90518482 |
| 116 | Ankle contracture (HP:0006466) | 1.90442947 |
| 117 | Stridor (HP:0010307) | 1.89241194 |
| 118 | Thoracic kyphosis (HP:0002942) | 1.88934235 |
| 119 | Hyporeflexia of lower limbs (HP:0002600) | 1.87908153 |
| 120 | Angiofibromas (HP:0010615) | 1.86293344 |
| 121 | Adenoma sebaceum (HP:0009720) | 1.86293344 |
| 122 | Hypoglycemic seizures (HP:0002173) | 1.86268435 |
| 123 | Global brain atrophy (HP:0002283) | 1.85412089 |
| 124 | Upper limb amyotrophy (HP:0009129) | 1.85394799 |
| 125 | Distal upper limb amyotrophy (HP:0007149) | 1.85394799 |
| 126 | Abnormality of the fingertips (HP:0001211) | 1.85353289 |
| 127 | Increased nuchal translucency (HP:0010880) | 1.85154259 |
| 128 | Progressive external ophthalmoplegia (HP:0000590) | 1.84916801 |
| 129 | Lower limb amyotrophy (HP:0007210) | 1.84147952 |
| 130 | Cerebral edema (HP:0002181) | 1.83995027 |
| 131 | Sudden death (HP:0001699) | 1.83267691 |
| 132 | Ventricular tachycardia (HP:0004756) | 1.82947746 |
| 133 | Deviation of the thumb (HP:0009603) | 1.82591578 |
| 134 | Selective tooth agenesis (HP:0001592) | 1.82389759 |
| 135 | Blue sclerae (HP:0000592) | 1.81179672 |
| 136 | Atrioventricular block (HP:0001678) | 1.81011521 |
| 137 | Advanced eruption of teeth (HP:0006288) | 1.80112087 |
| 138 | Hemorrhage of the eye (HP:0011885) | 1.79734529 |
| 139 | Bladder diverticulum (HP:0000015) | 1.79709617 |
| 140 | Insulin resistance (HP:0000855) | 1.79374190 |
| 141 | Generalized aminoaciduria (HP:0002909) | 1.79213439 |
| 142 | Deep palmar crease (HP:0006191) | 1.78578554 |
| 143 | Difficulty climbing stairs (HP:0003551) | 1.78309512 |
| 144 | Obstructive sleep apnea (HP:0002870) | 1.78179687 |
| 145 | Ependymoma (HP:0002888) | 1.76883149 |
| 146 | Increased variability in muscle fiber diameter (HP:0003557) | 1.76445648 |
| 147 | Short nail (HP:0001799) | 1.76323712 |
| 148 | Malnutrition (HP:0004395) | 1.76155823 |
| 149 | Breast hypoplasia (HP:0003187) | 1.76031407 |
| 150 | Asymmetry of the thorax (HP:0001555) | 1.75342890 |
| 151 | Abnormality of oral frenula (HP:0000190) | 1.75271554 |
| 152 | Mitral regurgitation (HP:0001653) | 1.74702181 |
| 153 | Abnormality of the gallbladder (HP:0005264) | 1.74411836 |
| 154 | Hand muscle atrophy (HP:0009130) | 1.74336942 |
| 155 | Natal tooth (HP:0000695) | 1.73740409 |
| 156 | Abnormality of iron homeostasis (HP:0011031) | 1.73546520 |
| 157 | Aneurysm (HP:0002617) | 1.73047425 |
| 158 | Generalized amyotrophy (HP:0003700) | 1.72935711 |
| 159 | Abnormality of the tricuspid valve (HP:0001702) | 1.72465871 |
| 160 | Cerebral inclusion bodies (HP:0100314) | 1.72439718 |
| 161 | Thin ribs (HP:0000883) | 1.71166394 |
| 162 | Exercise-induced myalgia (HP:0003738) | 1.70978307 |
| 163 | Microvesicular hepatic steatosis (HP:0001414) | 1.70871101 |
| 164 | Upper limb muscle weakness (HP:0003484) | 1.70088081 |
| 165 | Bowing of the arm (HP:0006488) | 1.69601583 |
| 166 | Bowed forearm bones (HP:0003956) | 1.69601583 |
| 167 | Proximal placement of thumb (HP:0009623) | 1.68901643 |
| 168 | Genu recurvatum (HP:0002816) | 1.67979994 |
| 169 | Hammertoe (HP:0001765) | 1.67908847 |
| 170 | Abnormality of glycolysis (HP:0004366) | 1.67629547 |
| 171 | Flat cornea (HP:0007720) | 1.65683293 |
| 172 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.64208002 |
| 173 | Squamous cell carcinoma (HP:0002860) | 1.63687038 |
| 174 | Upper motor neuron abnormality (HP:0002127) | 1.60770906 |
| 175 | Abnormal ossification of hand bones (HP:0005921) | 1.59401171 |
| 176 | Hyperparathyroidism (HP:0000843) | 1.59291821 |
| 177 | Bowel incontinence (HP:0002607) | 1.58921433 |
| 178 | Abnormality of carpal bone ossification (HP:0006257) | 1.58773274 |
| 179 | Nonimmune hydrops fetalis (HP:0001790) | 1.58276105 |
| 180 | Vertebral arch anomaly (HP:0008438) | 1.56148401 |
| 181 | Precocious puberty (HP:0000826) | 1.56091312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.06716467 |
| 2 | PKN2 | 4.96397535 |
| 3 | SMG1 | 4.26000703 |
| 4 | BCKDK | 3.92319752 |
| 5 | EEF2K | 3.22217001 |
| 6 | PRPF4B | 3.17726248 |
| 7 | IRAK3 | 2.97806689 |
| 8 | TTN | 2.74848621 |
| 9 | ERN1 | 2.71318583 |
| 10 | SIK1 | 2.49399154 |
| 11 | MAP3K10 | 2.44092771 |
| 12 | NEK1 | 2.43375133 |
| 13 | FLT3 | 2.06238217 |
| 14 | FGFR4 | 1.81861698 |
| 15 | CDK12 | 1.78921921 |
| 16 | PTK6 | 1.72679113 |
| 17 | LATS1 | 1.61074404 |
| 18 | PDK3 | 1.57376553 |
| 19 | PDK4 | 1.57376553 |
| 20 | RIPK1 | 1.51133749 |
| 21 | EPHA2 | 1.49926615 |
| 22 | PDGFRA | 1.49735045 |
| 23 | TAOK2 | 1.44928901 |
| 24 | NEK2 | 1.42471711 |
| 25 | SCYL2 | 1.38293874 |
| 26 | ARAF | 1.34931039 |
| 27 | MAP2K3 | 1.31609644 |
| 28 | MAP3K13 | 1.29054121 |
| 29 | CDK4 | 1.26930819 |
| 30 | MTOR | 1.25186879 |
| 31 | PRKD3 | 1.23607496 |
| 32 | LRRK2 | 1.22771972 |
| 33 | ICK | 1.16937618 |
| 34 | RPS6KB2 | 1.16934554 |
| 35 | WEE1 | 1.13593649 |
| 36 | BRAF | 1.12016180 |
| 37 | BMX | 1.10240156 |
| 38 | LATS2 | 1.09451033 |
| 39 | NME2 | 1.09398057 |
| 40 | PAK4 | 1.08886728 |
| 41 | TTK | 1.06632290 |
| 42 | PASK | 1.06175816 |
| 43 | MAPKAPK3 | 1.03423674 |
| 44 | MAPK11 | 1.03118221 |
| 45 | CDC7 | 1.01956705 |
| 46 | MAP3K8 | 1.00565780 |
| 47 | LMTK2 | 0.94903171 |
| 48 | MST1R | 0.94831710 |
| 49 | MET | 0.94500542 |
| 50 | CAMK1D | 0.93010526 |
| 51 | ALK | 0.88895458 |
| 52 | CDK6 | 0.88875485 |
| 53 | MAP3K9 | 0.88448976 |
| 54 | PIM2 | 0.85310754 |
| 55 | PAK2 | 0.82451652 |
| 56 | CHEK2 | 0.81946420 |
| 57 | NTRK1 | 0.79493377 |
| 58 | MAP3K3 | 0.79281599 |
| 59 | SIK2 | 0.77503566 |
| 60 | MAP3K7 | 0.76886575 |
| 61 | RPS6KA4 | 0.76273844 |
| 62 | PDPK1 | 0.75455318 |
| 63 | RPS6KA2 | 0.73229593 |
| 64 | ACVR1B | 0.71989475 |
| 65 | PTK2 | 0.70330319 |
| 66 | PDK2 | 0.68021016 |
| 67 | ERBB4 | 0.67928458 |
| 68 | STK38L | 0.65568603 |
| 69 | CDK8 | 0.64707582 |
| 70 | TGFBR1 | 0.64289292 |
| 71 | STK10 | 0.63379448 |
| 72 | TESK2 | 0.62997611 |
| 73 | CDK7 | 0.62325305 |
| 74 | CDC42BPA | 0.61662045 |
| 75 | IRAK2 | 0.61401219 |
| 76 | AKT2 | 0.61362994 |
| 77 | MAP3K11 | 0.60752919 |
| 78 | NEK9 | 0.60736557 |
| 79 | FGFR1 | 0.60703881 |
| 80 | TYRO3 | 0.59960070 |
| 81 | AURKB | 0.58509602 |
| 82 | ILK | 0.57865678 |
| 83 | MARK2 | 0.57527752 |
| 84 | KDR | 0.57154292 |
| 85 | BUB1 | 0.57151745 |
| 86 | EIF2AK1 | 0.56857633 |
| 87 | RET | 0.56706545 |
| 88 | STK3 | 0.53683959 |
| 89 | RAF1 | 0.53158306 |
| 90 | MAP3K1 | 0.52807000 |
| 91 | DDR2 | 0.51561155 |
| 92 | JAK2 | 0.50769220 |
| 93 | PRKAA1 | 0.50306117 |
| 94 | GRK6 | 0.49686275 |
| 95 | STK4 | 0.48051378 |
| 96 | BRSK2 | 0.47581599 |
| 97 | TAOK1 | 0.47305142 |
| 98 | PRKD2 | 0.46872534 |
| 99 | ATR | 0.46750408 |
| 100 | MAPK12 | 0.46209251 |
| 101 | KSR2 | 0.45728107 |
| 102 | CDK9 | 0.44475931 |
| 103 | RPS6KA6 | 0.44335288 |
| 104 | RPS6KA1 | 0.43958038 |
| 105 | PRKAA2 | 0.43920944 |
| 106 | ABL2 | 0.43175571 |
| 107 | MOS | 0.42549389 |
| 108 | MAP2K2 | 0.42365206 |
| 109 | PLK1 | 0.42178627 |
| 110 | CDK1 | 0.42137054 |
| 111 | BRSK1 | 0.40882621 |
| 112 | CDK11A | 0.40143408 |
| 113 | CLK1 | 0.40110733 |
| 114 | PIM1 | 0.39030591 |
| 115 | PAK1 | 0.37996773 |
| 116 | CHEK1 | 0.37839207 |
| 117 | DYRK1B | 0.37440905 |
| 118 | MAP2K1 | 0.37132112 |
| 119 | DAPK3 | 0.37122786 |
| 120 | TAOK3 | 0.36234166 |
| 121 | HIPK2 | 0.35759017 |
| 122 | TESK1 | 0.35357346 |
| 123 | CDK15 | 0.35025047 |
| 124 | GSK3A | 0.35020104 |
| 125 | OBSCN | 0.35014856 |
| 126 | PRKD1 | 0.33803877 |
| 127 | AURKA | 0.33102421 |
| 128 | MELK | 0.32829325 |
| 129 | CDK2 | 0.32458667 |
| 130 | MAP3K14 | 0.32445620 |
| 131 | TBK1 | 0.31433665 |
| 132 | CSNK1E | 0.31395291 |
| 133 | TSSK6 | 0.30565796 |
| 134 | EPHB1 | 0.29644760 |
| 135 | CAMKK1 | 0.29584166 |
| 136 | RPS6KL1 | 0.28739203 |
| 137 | RPS6KC1 | 0.28739203 |
| 138 | ERBB2 | 0.28550383 |
| 139 | CAMK1G | 0.28226259 |
| 140 | PDGFRB | 0.28191854 |
| 141 | TYK2 | 0.27016557 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.58758531 |
| 2 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.19759043 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.18448524 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.02067661 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.00116822 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.80841815 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.73106590 |
| 8 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.69302483 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.66530915 |
| 10 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.60914735 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.46581113 |
| 12 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.32049818 |
| 13 | Carbon metabolism_Homo sapiens_hsa01200 | 2.22198087 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.22184424 |
| 15 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.14742337 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.06242038 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.97861827 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.93547974 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.92820081 |
| 20 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.90017373 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.89803415 |
| 22 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.88637537 |
| 23 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.87301108 |
| 24 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.67009895 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.61802103 |
| 26 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.59044853 |
| 27 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.58874211 |
| 28 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.58670336 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.58436872 |
| 30 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.53406932 |
| 31 | Peroxisome_Homo sapiens_hsa04146 | 1.50877847 |
| 32 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.49522968 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.48877811 |
| 34 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.42941976 |
| 35 | Cell cycle_Homo sapiens_hsa04110 | 1.39089763 |
| 36 | Lysine degradation_Homo sapiens_hsa00310 | 1.34299059 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.33176877 |
| 38 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.28673594 |
| 39 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.28323300 |
| 40 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.26975333 |
| 41 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.26620116 |
| 42 | Bile secretion_Homo sapiens_hsa04976 | 1.21287481 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.18353704 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18033711 |
| 45 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.17253476 |
| 46 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.14152557 |
| 47 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.13824286 |
| 48 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.13276857 |
| 49 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.11456419 |
| 50 | Spliceosome_Homo sapiens_hsa03040 | 1.11137718 |
| 51 | Sulfur relay system_Homo sapiens_hsa04122 | 1.10715641 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.10094078 |
| 53 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.08231001 |
| 54 | Endometrial cancer_Homo sapiens_hsa05213 | 1.07508284 |
| 55 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.04668877 |
| 56 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.04411607 |
| 57 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.01558957 |
| 58 | Glioma_Homo sapiens_hsa05214 | 1.00772842 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.99968303 |
| 60 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.98886055 |
| 61 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.97868965 |
| 62 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.96430451 |
| 63 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.95118925 |
| 64 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.93760267 |
| 65 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.89185892 |
| 66 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.88301400 |
| 67 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88002713 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87918691 |
| 69 | Retinol metabolism_Homo sapiens_hsa00830 | 0.86861177 |
| 70 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.86356221 |
| 71 | Histidine metabolism_Homo sapiens_hsa00340 | 0.85862831 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.85083959 |
| 73 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.84856572 |
| 74 | Prostate cancer_Homo sapiens_hsa05215 | 0.82014823 |
| 75 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.80270924 |
| 76 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.78533521 |
| 77 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.75343134 |
| 78 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74989477 |
| 79 | Apoptosis_Homo sapiens_hsa04210 | 0.74956450 |
| 80 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.74177571 |
| 81 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.73671836 |
| 82 | ABC transporters_Homo sapiens_hsa02010 | 0.72489957 |
| 83 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72459715 |
| 84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.71842291 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.71200110 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70488931 |
| 87 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69716940 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69645321 |
| 89 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.68384800 |
| 90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.65578273 |
| 91 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64666308 |
| 92 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.64263300 |
| 93 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.63869440 |
| 94 | Hepatitis B_Homo sapiens_hsa05161 | 0.63799307 |
| 95 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61876653 |
| 96 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.61492704 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.61255253 |
| 98 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59848766 |
| 99 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.56580845 |
| 100 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.55974701 |
| 101 | Adherens junction_Homo sapiens_hsa04520 | 0.51045506 |
| 102 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.50552087 |
| 103 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.50238875 |
| 104 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.49267125 |
| 105 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.48270932 |
| 106 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.48110712 |
| 107 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.47941550 |
| 108 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.45428945 |
| 109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.44985867 |
| 110 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.43762455 |
| 111 | DNA replication_Homo sapiens_hsa03030 | 0.43506406 |
| 112 | Hepatitis C_Homo sapiens_hsa05160 | 0.43190116 |
| 113 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.42191539 |
| 114 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.40618170 |
| 115 | Lysosome_Homo sapiens_hsa04142 | 0.40479001 |
| 116 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39745522 |
| 117 | Bladder cancer_Homo sapiens_hsa05219 | 0.39185250 |
| 118 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.37040944 |
| 119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36543903 |
| 120 | Shigellosis_Homo sapiens_hsa05131 | 0.36406032 |
| 121 | Metabolic pathways_Homo sapiens_hsa01100 | 0.35636590 |
| 122 | Melanoma_Homo sapiens_hsa05218 | 0.35319157 |
| 123 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34626017 |
| 124 | RNA transport_Homo sapiens_hsa03013 | 0.33512429 |
| 125 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.33468373 |
| 126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.32793742 |
| 127 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.31087394 |
| 128 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30731540 |
| 129 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.22653968 |
| 130 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.21810105 |
| 131 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.20132140 |
| 132 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.16762689 |
| 133 | Prion diseases_Homo sapiens_hsa05020 | 0.16305044 |
| 134 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.16271081 |
| 135 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.15549102 |
| 136 | Thyroid cancer_Homo sapiens_hsa05216 | 0.14799961 |
| 137 | Mismatch repair_Homo sapiens_hsa03430 | 0.13794692 |
| 138 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.12126609 |
| 139 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.10961395 |
| 140 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.10932017 |
| 141 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.06561481 |
| 142 | Focal adhesion_Homo sapiens_hsa04510 | 0.04091664 |
| 143 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.03806445 |
| 144 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.03337862 |
| 145 | Base excision repair_Homo sapiens_hsa03410 | 0.03138153 |
| 146 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.03114887 |
| 147 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.02216687 |
| 148 | Amoebiasis_Homo sapiens_hsa05146 | 0.00817878 |

